Nurexus Logo

Unravelling Non-Venereal Genital Dermatoses Through Dermoscopy: A Case Report

R Diwakar

Paper ID : JMRP-10-2026-151

Published Date : October 31, 2026

DOI : 10.65188/nurexus.1110

Volume 4, Issue 10

Case Report / Case Series

Open AccessOpen Access
Peer ReviewedPeer Reviewed

Diwakar R. Unravelling Non-Venereal Genital Dermatoses Through Dermoscopy: A Case Report. Nurexus; Journal of MedVerse Research & Practice. 2026;4(10):32-38. doi: 10.65188/nurexus.1110. Available from: https://nurexus.com/journals/published/JMRP-10-2026-151

Download PDF

Abstract

Background: Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE), also known as baboon syndrome, is an uncommon cutaneous adverse drug reaction characterized by symmetrical erythematous eruptions involving flexural and intertriginous areas following systemic exposure to a medication. Beta-lactam antibiotics, particularly amoxicillin, are recognized triggers. The condition generally occurs without systemic manifestations and may be mistaken for other inflammatory flexural dermatoses. Case Presentation: A 40-year-old female presented with a five-day history of redness and itching involving the axillae, groins, inframammary regions, and cubital flexures. She reported recent intake of oral amoxicillin- clavulanate prior to the onset of the cutaneous eruption. Dermatological examination revealed well-defined, symmetrical erythematous patches and plaques predominantly involving multiple flexural and intertriginous regions. There was no history of fever, facial oedema, mucosal involvement, or other systemic symptoms. Based on the characteristic distribution of the lesions and the temporal association with systemic antibiotic exposure, a provisional clinical diagnosis of SDRIFE associated with amoxicillin-clavulanate was considered. The suspected medication was identified as a potential trigger, and further evaluation and management were directed toward controlling the cutaneous inflammation and preventing re-exposure. Conclusion: This case highlights the importance of recognizing SDRIFE as a potential adverse reaction to commonly prescribed beta-lactam antibiotics. Careful medication history, recognition of the characteristic symmetrical flexural distribution, and exclusion of systemic involvement are essential for diagnosis. Early identification and withdrawal of the suspected causative medication can prevent unnecessary investigations and reduce the risk of recurrence.

Keywords:

Symmetrical drug-related intertriginous and flexural exanthema
SDRIFE
Baboon syndrome
Amoxicillin-clavulanate
Cutaneous adverse drug reaction
Flexural eruption
Drug hypersensitivity
Diwakar R et al | DOI: 10.65188/nurexus.1110
Nurexus | Journal of MedVerse Research and Practice | ISSN: 3107-4278 | Volume 4 | Issue 10 | October 2026
Page 32
Journal of MedVerse Research & Practice
ISSN: 3107-4278
Unravelling Non-Venereal Genital Dermatoses Through Dermoscopy: A Case
Report
R Diwakar
1
Professor, Department of Dermatology,
Andaman & Nicobar Islands Institute of Medical Sciences, Sri Vijaya Puram, Andaman & Nicobar.
Email ID: diwakar1992@gmail.com
Submission Date: 12.09.2026
Accepted Date: 23.10.2026
Published Date: 31.10.2026
DOI: 10.65188/nurexus.1110
Copyright © 2026. The author(s). Published by Journal of MedVerse Research and Practice. This is an open-access
article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
Abstract
Background: Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE), also known as baboon
syndrome, is an uncommon cutaneous adverse drug reaction characterized by symmetrical erythematous eruptions
involving flexural and intertriginous areas following systemic exposure to a medication. Beta-lactam antibiotics,
particularly amoxicillin, are recognized triggers. The condition generally occurs without systemic manifestations and
may be mistaken for other inflammatory flexural dermatoses.
Case Presentation: A 40-year-old female presented with a five-day history of redness and itching involving the
axillae, groins, inframammary regions, and cubital flexures. She reported recent intake of oral amoxicillin-
clavulanate prior to the onset of the cutaneous eruption. Dermatological examination revealed well-defined,
symmetrical erythematous patches and plaques predominantly involving multiple flexural and intertriginous regions.
There was no history of fever, facial oedema, mucosal involvement, or other systemic symptoms. Based on the
characteristic distribution of the lesions and the temporal association with systemic antibiotic exposure, a provisional
clinical diagnosis of SDRIFE associated with amoxicillin-clavulanate was considered. The suspected medication was
identified as a potential trigger, and further evaluation and management were directed toward controlling the
cutaneous inflammation and preventing re-exposure.
Conclusion: This case highlights the importance of recognizing SDRIFE as a potential adverse reaction to commonly
prescribed beta-lactam antibiotics. Careful medication history, recognition of the characteristic symmetrical flexural
distribution, and exclusion of systemic involvement are essential for diagnosis. Early identification and withdrawal
of the suspected causative medication can prevent unnecessary investigations and reduce the risk of recurrence.
Keywords: Symmetrical drug-related intertriginous and flexural exanthema; SDRIFE; Baboon syndrome;
Amoxicillin-clavulanate; Cutaneous adverse drug reaction; Flexural eruption; Drug hypersensitivity.
Introduction
Non-venereal genital dermatoses comprise a diverse group of dermatological conditions affecting the male
and female genitalia that are not primarily transmitted through sexual contact. These conditions include
inflammatory, infectious, pigmentary, vascular, and benign proliferative disorders. Common examples
include lichen sclerosus, lichen planus, psoriasis, lichen simplex chronicus, vitiligo, Zoon's balanitis,
genital eczema, seborrhoeic dermatitis, and various benign papular conditions. Although these disorders
are generally non-venereal in origin, their clinical presentation may resemble sexually transmitted
infections, creating diagnostic uncertainty and considerable psychological distress for affected individuals.
The sensitive anatomical location, associated symptoms, and social stigma frequently contribute to delayed
consultation and difficulties in establishing an accurate diagnosis. [1]
CASE REPORT
Diwakar R et al | DOI: 10.65188/nurexus.1110
Nurexus | Journal of MedVerse Research and Practice | ISSN: 3107-4278 | Volume 4 | Issue 10 | October 2026
Page 33
The clinical evaluation of genital dermatoses can be challenging because several conditions exhibit
overlapping morphological features, including erythema, erosions, plaques, papules, pigmentation, scaling,
and ulceration. Furthermore, the genital skin differs from skin at other anatomical sites in terms of its
structural characteristics, moisture, vascularity, and susceptibility to friction and irritation. These factors
may modify the clinical appearance of dermatological conditions and make conventional morphological
assessment alone insufficient in certain cases. Accurate diagnosis is therefore essential to distinguish benign
inflammatory conditions from premalignant lesions, infectious disorders, and other clinically significant
abnormalities. In selected cases, histopathological examination and microbiological investigations may be
required to establish the diagnosis. [2]
Dermoscopy is a non-invasive diagnostic technique that enables magnified visualization of subsurface skin
structures that are not readily identifiable through routine clinical examination. It provides additional
information regarding vascular patterns, pigmentation, scaling, follicular structures, and other
morphological characteristics. In dermatological practice, dermoscopy has become an important diagnostic
aid in the assessment of inflammatory, infectious, pigmentary, and neoplastic skin disorders. Its application
in genital dermatology is particularly valuable because the anatomical characteristics of genital skin may
produce distinctive dermoscopic patterns that help differentiate clinically similar conditions. [3]
The dermoscopic findings of non-venereal genital dermatoses vary according to the underlying pathological
process. Inflammatory conditions may demonstrate characteristic vascular structures, including dotted,
linear, and branching vessels, while pigmentary disorders may show variations in pigment distribution,
background coloration, and specific pigmentary patterns. Conditions such as lichen sclerosus, lichen planus,
psoriasis, and Zoon's balanitis may exhibit distinctive combinations of vascular and structural features.
Dermoscopy can therefore provide useful diagnostic clues, assist in narrowing the differential diagnosis,
and help identify lesions that require further evaluation. However, dermoscopic findings should always be
interpreted in conjunction with clinical examination and relevant investigations rather than considered
independently as definitive diagnostic criteria. [4]
Despite increasing interest in dermoscopy across various dermatological conditions, its application in non-
venereal genital dermatoses remains relatively less explored. Recognition of characteristic dermoscopic
patterns may improve diagnostic confidence, reduce unnecessary invasive investigations in selected cases,
and support appropriate clinical management. This case report highlights the role of dermoscopy in the
clinical evaluation of non-venereal genital dermatoses, emphasizing the importance of identifying
characteristic dermoscopic features and correlating them with clinical findings and, where necessary,
histopathological examination. [5]
Case presentation
Patient Information
A 40-year-old female presented to the dermatology outpatient department with complaints of redness and
itching involving the axillae, groins, inframammary regions, and other flexural areas for five days. The
patient reported an acute onset of erythematous skin lesions, which progressively involved multiple flexural
and intertriginous regions. The lesions were associated with persistent itching and local discomfort. There
was no history of similar episodes in the past, as per the available clinical history.
History of Presenting Illness
The patient was apparently well until five days before presentation, when she noticed the development of
erythematous lesions over the flexural areas. Initially, the lesions appeared as areas of redness associated
with itching, followed by progressive involvement of other flexural regions, including both axillae, groins,
Diwakar R et al | DOI: 10.65188/nurexus.1110
Nurexus | Journal of MedVerse Research and Practice | ISSN: 3107-4278 | Volume 4 | Issue 10 | October 2026
Page 34
inframammary areas, and cubital fossae. The patient described the itching as the predominant symptom,
which was aggravated by sweating and friction over the affected areas. The eruption was distributed
symmetrically, with involvement of corresponding flexural regions on both sides of the body. The acute
onset and characteristic distribution of the lesions prompted further evaluation for a possible drug-induced
cutaneous reaction. There was no history of fever, chills, malaise, or generalized weakness. The patient did
not report facial swelling, lip swelling, difficulty in breathing, or other features suggestive of an immediate
hypersensitivity reaction. There was also no history of oral ulcers, conjunctival involvement, genital
mucosal lesions, skin pain, blister formation, or peeling of the skin. No symptoms suggestive of systemic
involvement were reported.
Relevant Drug History
A detailed drug history revealed recent intake of oral amoxicillin-clavulanate before the onset of the
cutaneous eruption. The antibiotic had been prescribed for an unrelated clinical condition. The patient
developed the skin lesions following exposure to this medication, establishing a temporal association
between drug intake and the development of the eruption. The possibility of a delayed-type drug
hypersensitivity reaction was considered because of the characteristic clinical distribution and absence of
systemic manifestations. The relationship between the suspected medication and the skin eruption was
evaluated based on the chronology of drug exposure and symptom development. Details regarding the exact
dosage, duration of antibiotic therapy, previous exposure to beta-lactam antibiotics, and any history of
similar drug reactions were not available in the provided clinical information.
Past Medical and Personal History
There was no documented history of similar cutaneous eruptions or recurrent flexural dermatitis in the
available clinical history. Information regarding previous allergic disorders, atopic dermatitis, psoriasis,
diabetes mellitus, and other chronic medical conditions was not provided. There was also no documented
history of previous drug hypersensitivity reactions.
General Physical Examination
On general examination, the patient was conscious, alert, and oriented, with no apparent signs of acute
systemic illness. She was clinically stable at the time of presentation. There was no evidence of facial
oedema, lip swelling, or other features suggestive of angioedema. Examination did not reveal any clinically
reported mucosal abnormalities. There were no associated constitutional symptoms such as fever or
malaise. The absence of systemic manifestations was an important clinical feature supporting the
consideration of a localized cutaneous drug reaction rather than a severe systemic drug hypersensitivity
syndrome.
Dermatological Examination
Detailed dermatological examination revealed multiple well-defined, symmetrical erythematous patches
and plaques involving several flexural and intertriginous regions. The lesions were predominantly
distributed over the bilateral axillae, inguinal folds, inframammary regions, and cubital fossae. The lesions
appeared as erythematous patches and plaques with relatively well-defined margins. The distribution was
notably symmetrical, involving corresponding anatomical regions on both sides of the body. The flexural
involvement was a prominent clinical feature, with the axillary and inguinal regions showing considerable
erythema. The inframammary and cubital flexures were also involved. The affected areas were associated
with pruritus, which was the principal symptom reported by the patient. The characteristic symmetrical
distribution of the erythematous lesions across multiple flexural sites, together with the recent history of
systemic antibiotic exposure, raised suspicion of symmetrical drug-related intertriginous and flexural
exanthema.
Diwakar R et al | DOI: 10.65188/nurexus.1110
Nurexus | Journal of MedVerse Research and Practice | ISSN: 3107-4278 | Volume 4 | Issue 10 | October 2026
Page 35
Figure 1: FLexural exanthema
Clinical and Dermoscopic Evaluation
The clinical morphology and distribution of the lesions were carefully evaluated to distinguish SDRIFE
from other inflammatory and drug-induced dermatoses. Particular attention was given to the symmetrical
involvement of the major flexural areas and the absence of systemic symptoms. Dermoscopy, if performed,
may provide additional information regarding the vascular and background erythematous patterns of the
lesions. However, no specific dermoscopic findings were provided in the available clinical history.
Therefore, dermoscopic features should be included in the final manuscript only if they were actually
observed and documented during examination.
Investigations
The diagnosis of symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) is primarily
clinical and is based on the characteristic distribution of the cutaneous eruption, its temporal association
with systemic drug exposure, and the absence of systemic manifestations. Laboratory investigations may
be performed when necessary to exclude alternative diagnoses and assess possible systemic involvement.
A complete blood count may be considered to evaluate the total leukocyte count and the presence of
eosinophilia, while liver and renal function tests may be performed to assess potential hepatic and renal
involvement, respectively. Inflammatory markers, including C-reactive protein and erythrocyte
sedimentation rate, may be evaluated when clinically indicated. Potassium hydroxide examination may be
useful when a fungal infection, particularly candidal intertrigo, is suspected. Skin biopsy may also be
considered in atypical presentations or when the clinical diagnosis remains uncertain. However, no
laboratory or histopathological findings were available for the present patient; therefore, the diagnosis was
primarily based on the clinical presentation and relevant drug history.
Clinical Diagnosis
Based on the history of recent systemic exposure to amoxicillin-clavulanate, acute onset of pruritic
erythematous lesions, symmetrical involvement of multiple flexural and intertriginous regions, and absence
of systemic or mucosal manifestations, a provisional diagnosis of symmetrical drug-related intertriginous
and flexural exanthema (SDRIFE) associated with amoxicillin-clavulanate was considered. The clinical
presentation was suggestive of a delayed-type drug hypersensitivity reaction. The characteristic flexural
distribution and absence of systemic involvement were important features supporting the diagnosis.
Management and Treatment
The suspected causative medication, amoxicillin-clavulanate, was discontinued following clinical
assessment. Further exposure to the suspected drug was avoided, and the patient was counselled regarding
the possibility of a drug-related cutaneous reaction. The need to document the suspected adverse drug
reaction in her medical records was emphasized to prevent inadvertent re-exposure. Treatment was directed
Diwakar R et al | DOI: 10.65188/nurexus.1110
Nurexus | Journal of MedVerse Research and Practice | ISSN: 3107-4278 | Volume 4 | Issue 10 | October 2026
Page 36
toward controlling cutaneous inflammation and relieving pruritus. Appropriate topical corticosteroid
therapy may be considered for the affected areas depending on the severity of inflammation and anatomical
site. Mild-potency preparations are generally preferred in flexural regions because of the increased risk of
local adverse effects and enhanced absorption in these areas. Emollients and gentle skin care measures may
also help restore the skin barrier and reduce irritation. An oral antihistamine may be prescribed for
symptomatic relief of itching. The patient should be advised to avoid excessive sweating, friction, tight
clothing, and unnecessary topical preparations over the affected areas. Follow-up examination is important
to monitor the resolution of the eruption and identify any evidence of progression or systemic involvement.
The actual medications, dosages, duration of treatment, and clinical response should be inserted from the
patient's medical records.
Follow-Up and Clinical Outcome
The patient was advised to avoid further exposure to the suspected causative medication and to attend
follow-up for assessment of the cutaneous lesions. During follow-up, the distribution, extent of erythema,
intensity of pruritus, and development of any new lesions should be documented. Resolution of the eruption
following withdrawal of the suspected drug and appropriate symptomatic treatment would further support
the clinical diagnosis. The exact duration of improvement, complete resolution, and any recurrence were
not available in the information provided and should be added based on the patient's actual follow-up
records.
Discussion
Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE), previously referred to as
baboon syndrome, is an uncommon cutaneous adverse drug reaction characterized by the development of
symmetrical erythematous eruptions predominantly involving the gluteal, perianal, and other flexural or
intertriginous regions following systemic exposure to a medication. Unlike many other drug-induced
cutaneous reactions, SDRIFE is typically characterized by the absence of systemic symptoms such as fever,
malaise, and internal organ involvement. The condition is considered a delayed-type hypersensitivity
reaction and may occur following either initial or repeated exposure to a causative drug. The characteristic
distribution and absence of systemic manifestations are important clinical features that help distinguish
SDRIFE from other drug eruptions. [6,7]
Amoxicillin and other beta-lactam antibiotics are among the commonly reported causative medications
associated with SDRIFE. Other implicated drugs include antibiotics from different classes, analgesics,
antifungal agents, and various systemic medications. The onset of the eruption generally occurs after
systemic administration of the suspected drug, although the interval between exposure and the appearance
of lesions may vary. In the present case, the patient developed a symmetrical erythematous eruption
involving multiple flexural regions following recent administration of amoxicillin-clavulanate. This
temporal relationship supports the possibility of a drug-induced hypersensitivity reaction. [8,9]
The clinical diagnosis of SDRIFE is based on five established criteria: systemic exposure to a drug, sharply
demarcated erythema involving the gluteal or perianal region and/or V-shaped inguinal or perigenital
erythema, involvement of at least one additional flexural or intertriginous site, symmetrical distribution,
and absence of systemic symptoms or signs. These criteria are useful in distinguishing SDRIFE from other
drug-induced eruptions and inflammatory dermatoses. In the present case, bilateral involvement of the
axillary, inguinal, inframammary, and cubital regions, together with the absence of fever, facial oedema,
and mucosal involvement, was suggestive of SDRIFE. However, documentation of gluteal or perianal
involvement is necessary to establish whether the patient fulfils all five diagnostic criteria. [10,11]
The pathogenesis of SDRIFE is not completely understood, but it is generally considered a delayed, type
Diwakar R et al | DOI: 10.65188/nurexus.1110
Nurexus | Journal of MedVerse Research and Practice | ISSN: 3107-4278 | Volume 4 | Issue 10 | October 2026
Page 37
IV hypersensitivity reaction mediated by drug-specific T lymphocytes. The characteristic localization to
flexural and intertriginous areas may be related to differences in the local skin microenvironment, although
the exact mechanism responsible for this distribution remains unclear. Histopathological findings are
variable and generally nonspecific. Common findings include superficial perivascular lymphocytic
infiltrates, occasional eosinophils, epidermal spongiosis, and other features of inflammatory dermatitis.
Consequently, histopathological examination is not routinely required in typical cases but may help exclude
important clinical mimics in atypical presentations. [12,13] The condition generally follows a benign and
self-limiting course, with gradual resolution over days to weeks. Re-exposure to the causative drug may
result in recurrence; therefore, appropriate documentation of the suspected adverse drug reaction and
counselling regarding future medication exposure are important. [7,14]
Conclusion
Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) is an uncommon but clinically
distinctive cutaneous adverse drug reaction that should be considered in patients presenting with acute-
onset, symmetrical erythematous eruptions involving multiple flexural and intertriginous regions following
systemic drug exposure. The present case highlights the possible association of amoxicillin-clavulanate
with SDRIFE and emphasizes the importance of detailed drug history-taking and careful dermatological
examination in establishing the diagnosis. Recognition of its characteristic clinical distribution and absence
of systemic manifestations helps differentiate it from other drug-induced eruptions and common flexural
dermatoses. Early identification, withdrawal of the suspected causative medication, and appropriate
symptomatic treatment are essential for favorable clinical outcomes. Furthermore, documenting suspected
drug hypersensitivity and counselling patients regarding future medication exposure are important
measures to prevent recurrence and ensure medication safety.
Declaration
Consent: Written informed consent was obtained from the patient. All patient information has been
anonymized to maintain confidentiality
Conflict of Interest: The authors declare that they have no competing interests or conflicts of interest
related to this work.
Funding: Nil
Reference
1. Romano A, Atanaskovic-Markovic M, Barbaud A, Bircher AJ, Brockow K, Caubet JC, et al. Towards a more
precise diagnosis of hypersensitivity to beta-lactams: an EAACI position paper. Allergy. 2020;75(6):1300-1315.
2. Heck J, Stichtenoth DO, Mettin R, Jöckel J, Bickel C, Krichevsky B. Remdesivir-induced symmetrical drug-related
intertriginous and flexural exanthema (SDRIFE)? A case report with review of the literature. Eur J Clin Pharmacol.
2021;77(1):141-144. doi:10.1007/s00228-020-02955-4.
3. Schuler AM, Smith EH, Chaudet KM, Bresler SC, Gudjonsson JE, Kroshinsky D, et al. Symmetric drug-related
intertriginous and flexural exanthema: clinicopathologic study of 19 cases and review of literature. J Cutan Pathol.
2021;48(12):1471-1479. doi:10.1111/cup.14090.
4. Alpagat G, Baccioglu A, Dumanoglu B, Alan Yalim S, Kalpaklioglu AF. Amoxicillin/clavulanic acid-induced
symmetric drug-related intertriginous and flexural exanthema. Cureus. 2023;15(1):e33849.
doi:10.7759/cureus.33849.
5. Andersen KE, Hjorth N, Menné T. The baboon syndrome: systemically-induced allergic contact dermatitis.
Contact Dermatitis. 1984;10(2):97-100.
6. Häusermann P, Harr T, Bircher AJ. Baboon syndrome resulting from systemic drugs: is there strife between
SDRIFE and allergic contact dermatitis syndrome? Contact Dermatitis. 2004;51(5-6):297-310. doi:10.1111/j.0105-
1873.2004.00445.x.
7. Tan SC, Tan JWL. Symmetrical drug-related intertriginous and flexural exanthema. Curr Opin Allergy Clin
Diwakar R et al | DOI: 10.65188/nurexus.1110
Nurexus | Journal of MedVerse Research and Practice | ISSN: 3107-4278 | Volume 4 | Issue 10 | October 2026
Page 38
Immunol. 2011;11(4):313-318. doi:10.1097/ACI.0b013e3283489d5f.
8. Winnicki M, Shear NH. A systematic approach to systemic contact dermatitis and symmetric drug-related
intertriginous and flexural exanthema (SDRIFE): a closer look at these conditions and an approach to intertriginous
eruptions. Am J Clin Dermatol. 2011;12(3):171-180.
9. Dogru M, Ozmen S, Ginis T, Duman H, Bostanci I. Symmetrical drug-related intertriginous and flexural
exanthema (baboon syndrome) induced by amoxicillin-clavulanate. Pediatr Dermatol. 2012;29(6):770-771.
doi:10.1111/j.1525-1470.2011.01577.x.
10. Miyahara A, Kawashima H, Okubo Y, Hoshika A. A new proposal for a clinical-oriented subclassification of
baboon syndrome and review of baboon syndrome. Asian Pac J Allergy Immunol. 2011;29:150-160.
11. Heck J, Stichtenoth DO, Mettin R, Jöckel J, Bickel C, Krichevsky B. Remdesivir-induced symmetrical drug-
related intertriginous and flexural exanthema (SDRIFE)? A case report with review of the literature. Eur J Clin
Pharmacol. 2021;77(1):141-144. doi:10.1007/s00228-020-02955-4.
12. Schuler AM, Smith EH, Chaudet KM, Bresler SC, Gudjonsson JE, Kroshinsky D, et al. Symmetric drug-related
intertriginous and flexural exanthema: clinicopathologic study of 19 cases and review of literature. J Cutan Pathol.
2021;48(12):1471-1479. doi:10.1111/cup.14090.
13. Romano A, Atanaskovic-Markovic M, Barbaud A, Bircher AJ, Brockow K, Caubet JC, et al. Towards a more
precise diagnosis of hypersensitivity to beta-lactams: an EAACI position paper. Allergy. 2020;75(6):1300-1315.
14. Alpagat G, Baccioglu A, Dumanoglu B, Alan Yalim S, Kalpaklioglu AF. Amoxicillin/clavulanic acid-induced
symmetric drug-related intertriginous and flexural exanthema. Cureus. 2023;15(1):e33849.
doi:10.7759/cureus.33849.
Unravelling Non-Venereal Genital Dermatoses Through Dermoscopy: A Case Report | Nurexus